Similar glycaemic control and less hypoglycaemia during active titration after insulin initiation with glargine 300 units/mL and degludec 100 units/mL: A subanalysis of the BRIGHT study

समान संसाधन

• Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes: A subanalysis from the BRIGHT trial
  द्वारा: Haluzík, Martin, और अन्य
  प्रकाशित: (2020)
• Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL and insulin degludec 100 U/mL in older participants in the BRIGHT trial
  द्वारा: Bolli, Geremia B., और अन्य
  प्रकाशित: (2021)
• Hypoglycaemia risk with insulin glargine 300 U/mL compared with glargine 100 U/mL across different baseline fasting C‐peptide levels in insulin‐naïve people with type 2 diabetes: A post hoc analysis of the EDITION 3 trial
  द्वारा: Bolli, Geremia B., और अन्य
  प्रकाशित: (2020)
• Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild‐to‐moderate renal impairment
  द्वारा: Javier Escalada, F., और अन्य
  प्रकाशित: (2018)
• Comparable glycaemic control and hypoglycaemia in adults with type 2 diabetes after initiating insulin glargine 300 units/mL or insulin degludec: The DELIVER Naïve D real‐world study
  द्वारा: Sullivan, Sean D., और अन्य
  प्रकाशित: (2019)